OR WAIT null SECS
Cardiocore, a centralized cardiac testing lab, announced its preferred provider status with a top 10 pharmaceutical company. Cardiocore was awarded cardiac safety service contracts in multi-year studies including a Thorough QT study and retrospective paper ECG analyses.
This is the company's second such announcement in the past three months. It had previously announced it was selected by an unnamed top 10 biotech.